[1] Pohla-Gubo G, Hintner H. Direct and indirect immunofluorescence for the diagnosis of bullous autoimmune diseases [J]. Dermatol Clin, 2011, 29(3): 365-372. [2] Suliman NM, Astrøm AN, Ali RW, et al. Clinical and histological characterization of oral pemphigus lesions in patients with skin diseases: a cross-sectional study from Sudan [J]. BMC Oral Health, 2013, 13(1): 66. [3] Arundhathi S, Ragunatha S, Mahadeva KC. A cross-sectional study of clinical, histopathological and direct immunofluorescence spectrum of vesiculobullous disorders [J]. J Clin Diagn Res, 2013, 7(12): 2788-2792. [4] 彭洋, 王明悦, 韩莹, 等. 黏膜性类天疱疮68例临床回顾分析[J]. 中华皮肤科杂志, 2013, 46(11): 788-791. [5] Baum S, Sakka N, Artsi O, et al. Diagnosis and classification of autoimmune blistering diseases [J]. Autoimmun Rev, 2014, 13(4): 482-489. [6] Kanwar AJ, De D. Pemphigus in India [J]. Indian J Dermatol Venereol Leprol,2011,77(4):439-449. [7] Inchara YK,Rajalakshmi T. Direct immunofluorescence in cutaneous vesiculobullous lesions[J]. Indian J Pathol Microbiol, 2007, 50(4): 730-732. [8] Sitaru C,Mihai S,Zillikens D. The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases[J]. Arch Dermatol Res,2007,299(1):1-8. [9] Hayashi I, Shinkuma S, Shimizu S, et al. Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type ⅩⅦ collagen [J]. Br J Dermatol, 2012, 166(5): 1116-1120. [10] Cozzani E, Drosera M, Parodi A, et al. Frequency of IgA antibodies in pemphigus, bullous pemphigoid and mucous membrane pemphigoid[J]. Acta Derm Venereol, 2004, 84(5):381-384. [11] Helander SD, Rogers RS 3rd .The sensitivity and specificity of direct immunofluorescene testing in disorders of mucous membranes[J]. J Am Dermatol, 1994, 30(1):65-75 . [12] 华红, 闫志敏. 寻常型天疱疮诊断和治疗的研究进展[J]. 现代口腔医学杂志, 2010, 24(2):81-85. 2014-08-04 收稿 2014-11-09 修回 本文编辑:杨永庆 |